Re: A few thoughts on Soliris(Eculizumab) vs. RVX-208 for Compliment-related disease
posted on
Sep 25, 2015 08:55AM
Great post Bear thanks. 26 weeks
Possibly? Very exciting. Correct me if I'm wrong but didn't RVX reach a PPS of $29 during a PII trial? And we'll have a pIII trial going on at the same time. Future looks good. :)